Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
J.-P. Clement MD

J.-P. Clement MD

Executive Pharmacovigilance Consulting

Connect with J.-P. Clement MD on LinkedIn
Website:

About the author: Dr. Clement is an Executive Pharmacovigilance Consultant for the pharmaceutical industry. He has worked over the last 26 years in Drug Safety and Pharmacovigilance in multiple capacities, mostly with global PV responsibilities at the VP level. He has worked for companies such as Janssen, Merck KgA, Abbott, Sanofi, Onyx and Cubist His consulting practice focuses on helping Pharmaceutical Companies to design and implement highly efficient and compliant PV structures and processes, with high strategic output. Dr. Clement graduated in Family Medicine from Pierre and Marie Curie Medical University, Paris, France, and worked in clinical practice for 8 years before joining the pharmaceutical industry. He also studied Pharmacology at Pierre & Marie Curie Paris 6, Lariboisiere Paris 5 and Claude Bernard Lyon Universities, France.

Posts by J.-P. Clement MD

The Art of CAPA Writing

Posted on February 13th, 2017 in Pharmacovigilance

Corrective and Preventive Actions (CAPAs) are a fundamental element of correcting deviation compliance in a regulated and quality Pharmacovigilance environment. (more…)

Outsourcing PV: Keys for a Successful Partnership

Posted on January 25th, 2017 in Pharmacovigilance

This is the last of the blog series on outsourcing PV activities. At this stage, you have identified what PV activities to outsource, the due diligence is complete and the best vendor is identified. (more…)

Outsourcing PV: Selecting your Partner

Posted on January 23rd, 2017 in Pharmacovigilance

Once you know what functions and expertise you want to keep in house and what are the PV activities you want to outsource, the next challenge will be to identify potential partners and pick-up the one which will fit your PV needs for the years to come. (more…)

Outsourcing PV: Core Competencies

Posted on December 7th, 2016 in Pharmacovigilance

In a previous posting, we reviewed the drivers for the decision to outsource some or all pharmacovigilance (PV) activities. What activity to outsource is the next critical step. (more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6